Martínez-Rovira I, Prezado Y
Laboratoire d'Imagerie et Modélisation en Neurobiologie et Cancérologie (IMNC), Centre National de la Recherche Scientifique (CNRS), Université Paris 7 and 11, Campus Universitaire, Bât. 440, 1er étage, 15 rue Georges Clemenceau, Orsay Cedex 91406, France.
Med Phys. 2015 Nov;42(11):6703-10. doi: 10.1118/1.4934370.
The outcome of radiotherapy can be further improved by combining irradiation with dose enhancers such as high-Z nanoparticles. Since 2004, spectacular results have been obtained when low-energy x-ray irradiations have been combined with nanoparticles. Recently, the same combination has been explored in hadron therapy. In vitro studies have shown a significant amplification of the biological damage in tumor cells charged with nanoparticles and irradiated with fast ions. This has been attributed to the increase in the ionizations and electron emissions induced by the incident ions or the electrons in the secondary tracks on the high-Z atoms, resulting in a local energy deposition enhancement. However, this subject is still a matter of controversy. Within this context, the main goal of the authors' work was to provide new insights into the dose enhancement effects of nanoparticles in proton therapy.
For this purpose, Monte Carlo calculations (gate/geant4 code) were performed. In particular, the geant4-DNA toolkit, which allows the modeling of early biological damages induced by ionizing radiation at the DNA scale, was used. The nanometric radial energy distributions around the nanoparticle were studied, and the processes (such as Auger deexcitation or dissociative electron attachment) participating in the dose deposition of proton therapy treatments in the presence of nanoparticles were evaluated. It has been reported that the architecture of Monte Carlo calculations plays a crucial role in the assessment of nanoparticle dose enhancement and that it may introduce a bias in the results or amplify the possible final dose enhancement. Thus, a dosimetric study of different cases was performed, considering Au and Gd nanoparticles, several nanoparticle sizes (from 4 to 50 nm), and several beam configurations (source-nanoparticle distances and source sizes).
This Monte Carlo study shows the influence of the simulations' parameters on the local dose enhancement and how more realistic configurations lead to a negligible increase of local energy deposition. The obtained dose enhancement factor was up to 1.7 when the source was located at the nanoparticle surface. This dose enhancement was reduced when the source was located at further distances (i.e., in more realistic situations). Additionally, no significant increase in the dissociative electron attachment processes was observed.
The authors' results indicate that physical effects play a minor role in the amplification of damage, as a very low dose enhancement or increase of dissociative electron attachment processes is observed when the authors get closer to more realistic simulations. Thus, other effects, such as biological or chemical processes, may be mainly responsible for the enhanced radiosensibilization observed in biological studies. However, more biological studies are needed to verify this hypothesis.
通过将辐射与高原子序数纳米颗粒等剂量增强剂相结合,放疗效果可得到进一步改善。自2004年以来,低能X射线辐射与纳米颗粒联合使用已取得显著成果。最近,这种联合方式也在强子治疗中得到了探索。体外研究表明,在充满纳米颗粒并接受快离子照射的肿瘤细胞中,生物损伤有显著放大。这归因于入射离子或二次径迹中的电子在高原子序数原子上引起的电离和电子发射增加,导致局部能量沉积增强。然而,这一问题仍存在争议。在此背景下,作者工作的主要目标是为纳米颗粒在质子治疗中的剂量增强效应提供新的见解。
为此进行了蒙特卡罗计算(GATE/geant4代码)。特别使用了geant4-DNA工具包,它能够在DNA尺度上对电离辐射诱导的早期生物损伤进行建模。研究了纳米颗粒周围的纳米级径向能量分布,并评估了在存在纳米颗粒的情况下参与质子治疗剂量沉积的过程(如俄歇去激发或解离电子附着)。据报道,蒙特卡罗计算的架构在评估纳米颗粒剂量增强中起着关键作用,可能会在结果中引入偏差或放大可能的最终剂量增强。因此,考虑到金和钆纳米颗粒、几种纳米颗粒尺寸(4至50纳米)以及几种射束配置(源-纳米颗粒距离和源尺寸),对不同情况进行了剂量学研究。
这项蒙特卡罗研究显示了模拟参数对局部剂量增强的影响,以及更实际的配置如何导致局部能量沉积的增加可忽略不计。当源位于纳米颗粒表面时,获得的剂量增强因子高达1.7。当源位于更远距离时(即更实际的情况),这种剂量增强会降低。此外,未观察到解离电子附着过程有显著增加。
作者的结果表明,物理效应在损伤放大中起的作用较小,因为当作者更接近更实际的模拟时,观察到剂量增强非常低或解离电子附着过程增加。因此,其他效应,如生物或化学过程,可能是生物学研究中观察到的放射增敏增强的主要原因。然而,需要更多的生物学研究来验证这一假设。